Let’s compare Trumps drug plan vs Biden’s.
President Trump has always pushed the policy of drug companies on their own and not by government mandates bring down the cost of drugs. Biden used the law but only pushed drugs that were covered by Medicare. And not all of them. Trumps method covered all drugs for all who take them. Not just those over 65.
Side‑by‑Side Comparison (Fact‑Only)
| Feature | Trump MFN Deals | Biden IRA Negotiation |
|---|---|---|
| Who benefits? | All consumers | Medicare only |
| Number of companies involved | 26 drugmakers | Not applicable |
| Speed | Immediate discounts | Multi‑year rollout |
| Scope | Cash prices → entire market | Medicare Part D/B only |
| Drug count | Varies by company | 10 → 15 → 15 → 20 per year |
| Benchmarking | Yes — foreign prices | No |
Trump’s MFN drug‑pricing deals benefit a larger number of people because they reduce cash prices for the entire population. Biden’s IRA negotiations benefit only Medicare beneficiaries.
Approximate Number of People Covered by Drug‑Pricing Policies
| Policy | Approximate People Covered | Coverage Scope | Key Mechanism |
|---|---|---|---|
| Trump’s “Most Favored Nation” Deals | ≈ 330 million | Entire U.S. population (cash‑price reductions apply to all consumers) | Voluntary price‑cut agreements with 26 drugmakers; foreign price benchmarking |
| Biden’s Inflation Reduction Act (IRA) Negotiations | ≈ 65 million | Medicare beneficiaries only |
